全球无针给药市场 – 行业趋势及 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球无针给药市场 – 行业趋势及 2028 年预测

  • Medical Devices
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 页面
  • 桌子數: 60
  • 图号: 220

Global Needle Free Drug Delivery Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 13.09 Billion
Diagram Market Size (Forecast Year)
USD 27.96 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Antares Pharmed
  • Tianjin Xuying Technology Development Co.
  • Verdict Media Limited
  • 3M PharmaJet
  • Zogenix

>全球无针给药市场,按产品(预充无针注射系统和可充无针注射系统)、技术(吸入器、新型无针、喷射注射器和透皮贴剂)、应用(胰岛素输送、疫苗接种、儿科注射和疼痛管理)、注射方法(粉末注射、液体注射和储库或弹丸注射)、动力源(弹簧负载喷射注射器系统、气体粉末喷射注射器和电池粉末喷射注射器系统)、国家(美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)行业趋势和预测到 2028 年

无针给药市场全球无针给药市场的市场分析和见解

预计无针药物输送市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称,到 2028 年,该市场规模将达到 210.4 亿美元,在上述预测期内的复合年增长率为 9.95%。糖尿病和慢性病的患病率不断上升,以及对无痛药物输送的需求直接影响了无针药物输送市场的增长。

无针药物输送系统是一种创新的药物和其他类型药物输送方式和方法。它们也可以是透皮贴剂、吸入系统,甚至是不会像传统针头那样刺穿皮肤的微针。

全球糖尿病患病率高是推动无针药物输送市场的主要因素。减少与常规针头输送方法相关的感染和疼痛传播风险是无针药物输送市场增长的主要机会。

与该设备相关的限制和缺点,例如由于组织卡在针头开口处而导致的堵塞和药物流动受限,是无针药物输送市场面临的主要挑战。然而,这些设备的高成本是 2021-2028 年预测期内无针药物输送市场增长的主要制约因素。

This needle-free drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research needle-free drug delivery market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

In May 2018, Namaste Technologies Inc. partnered with Inolife Sciences to commercialize and apply Inolife’s needle-free technology to deliver medical cannabis. The company aims for producing medical cannabis oil via this partnership.

Needle-Free Drug Delivery Market Scope and Market Size

Needle-free drug delivery market is segmented on the basis of product, technology, application, injection method and source of power. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on product, the needle-free drug delivery market is segmented into prefilled needle-free injection systems and fillable needle-free injection systems.
  • Based on technology, the needle-free drug delivery market is segmented into inhaler, novel needle-free, jet injector and transdermal patch.
  • On basis of application, the needle-free drug delivery market is segmented into insulin delivery, vaccination, pediatric injections and pain management.
  • Based on injection method, the needle-free drug delivery market is segmented into powder injections, liquid injections and depot or projectile injection.
  • Based on source of power, the needle-free drug delivery market is segmented into spring load jet injector systems, gas powdered jet injector and battery powdered jet injector system.

Needle-Free Drug Delivery Market Country Level Analysis

Needle-free drug delivery market is analysed and market size insights and trends are provided by country, product, technology, application, injection method and source of power as referenced above.

The countries covered in the needle-free drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is likely to lead the needle-free drug delivery market. High awareness regarding potential benefits of needle-free drug delivery devices and presence of well-developed healthcare facilities and extensive R&D expenditure by government organizations and pharmaceutical companies for diabetes and chronic pain management is the key factor for the growth of needle-free drug delivery market in this region. The market in Asia-Pacific is expected to exhibit a substantial growth rate during the forecast period 2021-2028 due to rising prevalence of diabetes in developing countries such as India and China.

The country section of the needle-free drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Needle-free drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for needle-free drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the needle-free drug delivery market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Needle-Free Drug Delivery Market Share Analysis

无针药物输送市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对无针药物输送市场的关注有关。

无针药物输送市场报告中涉及的主要参与者包括 Antares Pharmed, Inc.、天津旭英科技发展有限公司、Verdict Media Limited、3M、PharmaJet、Zogenix、Inovio Pharmaceuticals Inc.、Valeritas Inc、Akra Dermo-Jet、D'Antonio Consultants International Inc.、Endo Pharmaceuticals Inc.、BD、CROSSJECT、MIT Canada、MedImmune、Mystic Pharmaceuticals、Needle Free Injection System、Inolife Sciences、Ferring BV、OptiNose US Inc. 和 Pfizer Inc. 等国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Global Needle-Free Drug Delivery Market Segmentation, By Product (Prefilled Needle-Free Injection Systems and Fillable Needle-Free Injection Systems), Technology (Inhaler, Novel Needle-Free, Jet Injector and Transdermal Patch), Application (Insulin Delivery, Vaccination, Pediatric Injections, and Pain Management), Injection Method (Powder injections, Liquid injections, and Depot or Projectile Injection), Source of Power (Spring Load Jet Injector Systems, Gas Powdered Jet Injector, and Battery Powdered Jet Injector System) – Industry Trends and Forecast to 2031 .
The Global Needle Free Drug Delivery Market size was valued at USD 13.09 USD Billion in 2023.
The Global Needle Free Drug Delivery Market is projected to grow at a CAGR of 9.95% during the forecast period of 2024 to 2031.
The major players operating in the market include Antares Pharmed , Tianjin Xuying Technology Development Co. , Verdict Media Limited, 3M PharmaJet, Zogenix, Inovio Pharmaceuticals , Valeritas , Akra Dermo-Jet, D'Antonio Consultants International , Endo Pharmaceuticals , BD, CROSSJECT MIT Canada, MedImmune, Mystic Pharmaceuticals, Needle Free Injection System, Inolife Sciences, Ferring B.V., OptiNose US , Pfizer -.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.